Dynamic of broad H3K4me3 domains uncover an epigenetic switch between cell identity and cancer-related genes
- Mohamed Belhocine1,
- Mathieu Simonin2,
- José David Abad Flores3,
- Agata Cieslak2,
- Iris Manosalva3,
- Lydie Pradel3,
- Charlotte Smith2,
- Eve-Lyne Mathieu3,
- Guillaume Charbonnier3,
- Joost H.A. Martens4,
- Hendrik G. Stunnenberg4,
- Muhammad Ahmad Maqbool5,
- Aneta Mikulasova6,
- Lisa J. Russell7,
- Daniel Rico6,
- Denis Puthier3,
- Pierre Ferrier8,
- Vahid Asnafi2 and
- Salvatore Spicuglia3,9
- 1 Aix-Marseille University, Inserm, Theories and Approaches of Genomic Complexity (TAGC), Molecular Biology and Genetics Laboratory;
- 2 Université de Paris, Institut Necker-Enfants Malades, Institut national de la santé et de la recherche médicale, Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux;
- 3 Aix-Marseille University, Inserm, Theories and Approaches of Genomic Complexity (TAGC);
- 4 Radboud Institute for Molecular Life Sciences, Radboud University;
- 5 Cancer Research UK Manchester Institute, The University of Manchester;
- 6 Biosciences Institute, Newcastle University;
- 7 Translational and Clinical Research Institute, Newcastle University;
- 8 Aix-Marseille University, CNRS, INSERM
Abstract
Broad domains of H3K4 methylation have been associated with consistent expression of tissue-specific, cell identity, and tumor suppressor genes. Here, we identified broad domain-associated genes in healthy human thymic T cell populations and a collection of T-Acute Lymphoblastic Leukemia (T-ALL) primary samples and cell lines. We found that broad domains are highly dynamic throughout T cell differentiation and their varying breadth allows the distinction between normal and neoplastic cells. While broad domains preferentially associate with cell identity and tumor suppressor genes in normal thymocytes, they flag key oncogenes in T-ALL samples. Moreover, the expression of broad domain-associated genes, both coding and noncoding, is frequently deregulated in T-ALL. Using two distinct leukemic models, we demonstrated that the ectopic expression of T-ALL oncogenic transcription factor preferentially impacts the expression of broad domain-associated genes in pre-leukemic cells. Finally, an H3K4me3 demethylase inhibitor differentially targets T-ALL cell lines depending on the extent and number of broad domains. Our results show that the regulation of broad H3K4me3 domains is associated with leukemogenesis and suggest that the presence of these structures might be used as epigenetic prioritization of cancer-relevant genes, including long non-coding RNAs.
- Received June 15, 2020.
- Accepted May 5, 2021.
- Published by Cold Spring Harbor Laboratory Press
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see https://genome.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.
